Max: LS9

How about petrol made from bacteria?

LS9

LS9 combines core competencies in industrial biotechnology and synthetic biology to design, develop, and commercialize industrial bioprocesses. Industrial biotechnology is the application of biocatalysis for the large scale production of chemical products. Synthetic biology is the state of the art of bioengineering, and refers to the design, construction, and improvement of biological machines at the molecular genetic level. Bringing experience in industrial biotechnology from Cargill, Codexis, Genencor, Kosan, Cubist, and Verenium (formerly Diversa) and synthetic biology from Harvard, UC Berkeley, MIT, and Stanford, the LS9 team is uniquely suited to design, develop, and commercialize the next generation of biofuels.

To replace fossil fuel with a cost effective and renewable surrogate, LS9 has first looked to nature. The components of petroleum have biological counterparts, and the biological mechanisms for their synthesis are useful tools for the creation of new industrial processes. Employing the tools of biochemical engineering, LS9 has identified the key components of a cost effective process and defined which are best controlled physically, chemically, and biologically. Using synthetic biology, LS9 has reached into nature and accessed the required biological tools, engineered them to function under industrial conditions, and is optimizing their performance to meet our economic objectives. In this way LS9 is rapidly bringing its Renewable PetroleumTM technologies out of the lab and into the world.